Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levels.

Kathryn GazelakisIsabel ChuCatherine MartinMiles Patrick Sparrow

Published in: Internal medicine journal (2023)

Infections in patients with IBD were common, and the risk was highest with combination therapy. Infections were not associated with high serum anti-TNF levels.

Keyphrases

combination therapy
rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
emergency department
stem cells
cell therapy
bone marrow
patient reported
patient reported outcomes
ulcerative colitis
electronic health record